| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| LaTrice Montgomery, Shapree Dixon, Dale S Mante. Racial and Ethnic Differences in Cannabis Use and Cannabis Use Disorder: Implications for Researchers. Current addiction reports. vol 9. issue 1. 2022-03-07. PMID:35251891. |
this review provides an overview of recent studies on cannabis and cud by race/ethnicity and a discussion of implications for cannabis researchers. |
2022-03-07 |
2023-08-13 |
Not clear |
| Shana M Augustin, David M Lovinge. Synaptic changes induced by cannabinoid drugs and cannabis use disorder. Neurobiology of disease. 2022-02-27. PMID:35219856. |
like many drugs of abuse, cannabis and cannabis-derived drugs are prone to misuse, and long-term usage can lead to drug tolerance and the development of cannabis use disorder (cud). |
2022-02-27 |
2023-08-13 |
Not clear |
| Shana M Augustin, David M Lovinge. Synaptic changes induced by cannabinoid drugs and cannabis use disorder. Neurobiology of disease. 2022-02-27. PMID:35219856. |
despite the widespread use of cannabis and cannabinoids as therapeutic agents, little is known about the neurobiological mechanisms associated with cud and cannabinoid drug use. |
2022-02-27 |
2023-08-13 |
Not clear |
| Karolina Kozak Bidzinski, Darby J E Lowe, Marcos Sanches, Maryam Sorkhou, Isabelle Boileau, Michael Kiang, Daniel M Blumberger, Gary Remington, Clement Ma, David J Castle, Rachel A Rabin, Tony P Georg. Investigating repetitive transcranial magnetic stimulation on cannabis use and cognition in people with schizophrenia. NPJ schizophrenia. vol 8. issue 1. 2022-02-25. PMID:35210458. |
cannabis use disorder (cud) occurs at high rates in schizophrenia, which negatively impacts its clinical prognosis. |
2022-02-25 |
2023-08-13 |
human |
| Karolina Kozak Bidzinski, Darby J E Lowe, Marcos Sanches, Maryam Sorkhou, Isabelle Boileau, Michael Kiang, Daniel M Blumberger, Gary Remington, Clement Ma, David J Castle, Rachel A Rabin, Tony P Georg. Investigating repetitive transcranial magnetic stimulation on cannabis use and cognition in people with schizophrenia. NPJ schizophrenia. vol 8. issue 1. 2022-02-25. PMID:35210458. |
we examined the effects of active versus sham high-frequency (20-hz) repetitive transcranial magnetic stimulation (rtms) on cannabis use in outpatients with schizophrenia and cud. |
2022-02-25 |
2023-08-13 |
human |
| Abdul Kareem Zalikha, Dalia Rahmon, Matthew Mazur, Inaya Hajj Hussein, Mouhanad M El-Othman. Cannabis Use Disorder in the Setting of Primary Total Hip Arthroplasty: Understanding the Epidemiology, Demographic Characteristics, and Inpatient Postoperative Outcomes. The Journal of the American Academy of Orthopaedic Surgeons. 2022-02-25. PMID:35213453. |
the purpose of this study was to report on the epidemiologic and demographic characteristics and inpatient postoperative outcomes of patients with cannabis use disorder (cud) undergoing primary total hip arthroplasty (tha). |
2022-02-25 |
2023-08-13 |
Not clear |
| Rishi Sharma, Sai Krishna Tikka, Ashish Ramesh Bhute, Binaya Kumar Basti. N-acetyl cysteine in the treatment of cannabis use disorder: A systematic review of clinical trials. Addictive behaviors. vol 129. 2022-02-21. PMID:35189496. |
cannabis is the most consumed illicit drug globally, with a high risk of developing cannabis use disorder (cud). |
2022-02-21 |
2023-08-13 |
Not clear |
| Miriam D Weisberg, Mitchell K Ng, Matthew L Magruder, Rushabh M Vakharia, Martin W Roche, Orry Ere. The Association of Cannabis Use Disorder and Perioperative Complications After Primary Total Knee Arthroplasty. The Journal of the American Academy of Orthopaedic Surgeons. 2022-02-16. PMID:35171881. |
although studies have shown the implications of substance use on total joint arthroplasty, studies investigating the association of patients exclusively who have cannabis use disorder (cud) after primary total knee arthroplasty (tka) are sparse. |
2022-02-16 |
2023-08-13 |
Not clear |
| Llewellyn Mills, Nicholas Lintzeris, Michael O'Malley, Jonathon C Arnold, Iain S McGrego. Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical condition. Drug and alcohol review. 2022-02-16. PMID:35172040. |
prior research has examined the prevalence and correlates of cannabis use disorder (cud) in people who use cannabis; however, these are poorly described for people using cannabis for medical reasons. |
2022-02-16 |
2023-08-13 |
Not clear |
| Dorothy Wallis, J Douglas Coatsworth, Jeremy Mennis, Nathaniel R Riggs, Nikola Zaharakis, Michael A Russell, Aaron R Brown, Stephanie Rayburn, Aubrie Radford, Christopher Hale, Michael J Maso. Predicting Self-Medication with Cannabis in Young Adults with Hazardous Cannabis Use. International journal of environmental research and public health. vol 19. issue 3. 2022-02-15. PMID:35162872. |
these results suggest widespread self-medication among young adults with likely cud and underscore the complexity of their cannabis use. |
2022-02-15 |
2023-08-13 |
human |
| Fiene Marie Kuijper, Uma V Mahajan, Seul Ku, Daniel A N Barbosa, Sheila M Alessi, Sherman C Stein, Kyle M Kampman, Brandon S Bentzley, Casey H Halper. Deep Brain Stimulation Compared With Contingency Management for the Treatment of Cocaine Use Disorders: A Threshold and Cost-Effectiveness Analysis. Neuromodulation : journal of the International Neuromodulation Society. vol 25. issue 2. 2022-02-07. PMID:35125144. |
cocaine is the second most frequently used illicit drug worldwide (after cannabis), and cocaine use disorder (cud)-related deaths increased globally by 80% from 1990 to 2013. |
2022-02-07 |
2023-08-13 |
Not clear |
| Richard J Macatee, Thomas J Preston, Kaveh Afshar, Norman B Schmidt, Jesse R Cougl. Impact of a computerized distress intolerance intervention on electrocortical reactivity to cannabis and threat cues: A randomized controlled trial. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. 2022-02-07. PMID:35129994. |
given increasing rates of daily cannabis use and cannabis use disorder (cud) in the united states, it is imperative to understand cud mechanisms in high-risk groups. |
2022-02-07 |
2023-08-13 |
Not clear |
| Richard J Macatee, Thomas J Preston, Kaveh Afshar, Norman B Schmidt, Jesse R Cougl. Impact of a computerized distress intolerance intervention on electrocortical reactivity to cannabis and threat cues: A randomized controlled trial. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. 2022-02-07. PMID:35129994. |
cannabis users with high distress intolerance (di) are at elevated risk for severe and chronic cud, but neural mechanisms linking cud and di are unknown. |
2022-02-07 |
2023-08-13 |
Not clear |
| Jacob T Borodovsky, Michael J Sofis, Brian J Sherman, Kevin M Gray, Alan J Budne. Characterizing cannabis use reduction and change in functioning during treatment: Initial steps on the path to new clinical endpoints. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. 2022-01-27. PMID:35084903. |
reduction-based cannabis use endpoints are needed to better evaluate treatments for cannabis use disorder (cud). |
2022-01-27 |
2023-08-13 |
Not clear |
| Kate Wolitzky-Taylor, Suzette Glasner, Alexandra Tanner, Dara G Ghahremani, Edythe D Londo. Targeting maladaptive reactivity to negative affect in emerging adults with cannabis use disorder: A preliminary test and proof of concept. Behaviour research and therapy. vol 150. 2022-01-15. PMID:35032700. |
cannabis use disorder (cud) is a growing public health concern, and is highly comorbid with negative affective conditions such as anxiety and depression. |
2022-01-15 |
2023-08-13 |
Not clear |
| Rikinkumar S Patel, Zainab Cheema, Ashima Singla, Miglia Cornejo, Geetika Verm. Cannabis Use is an Independent Risk Factor for Manic Episode: A Report from 380,265 Bipolar Inpatients. Substance use & misuse. 2021-12-13. PMID:34895014. |
to evaluate the odds for bipolar disorder (bp) mania and depression-related hospitalization due to cannabis use disorders (cud). |
2021-12-13 |
2023-08-13 |
Not clear |
| Meyyammai Narayanan, Khaled I Alnahhal, Ranjana Lingutla, Ali Irshad, Mark Iafrati, Luis Suarez, Shivani Kumar, Payam Saleh. Outcomes of Infrainguinal Bypass in Patients with Cannabis vs Opioid Use Disorder Outcomes of IIB in Patients with CUD vs OUD. Annals of vascular surgery. 2021-12-13. PMID:34902470. |
outcomes of infrainguinal bypass in patients with cannabis vs opioid use disorder outcomes of iib in patients with cud vs oud. |
2021-12-13 |
2023-08-13 |
Not clear |
| Meyyammai Narayanan, Khaled I Alnahhal, Ranjana Lingutla, Ali Irshad, Mark Iafrati, Luis Suarez, Shivani Kumar, Payam Saleh. Outcomes of Infrainguinal Bypass in Patients with Cannabis vs Opioid Use Disorder Outcomes of IIB in Patients with CUD vs OUD. Annals of vascular surgery. 2021-12-13. PMID:34902470. |
cannabis use disorder (cud) and opioid use disorder (oud) are associated with adverse effects on public health and postoperative outcomes. |
2021-12-13 |
2023-08-13 |
Not clear |
| Aimee L McRae-Clark, Kevin M Gray, Nathaniel L Baker, Brian J Sherman, Lindsay Squeglia, Gregory L Sahlem, Amanda Wagner, Rachel Tomk. Varenicline as a treatment for cannabis use disorder: A placebo-controlled pilot trial. Drug and alcohol dependence. vol 229. issue Pt B. 2021-12-12. PMID:34655945. |
an efficacious pharmacotherapy for cannabis use disorder (cud) has yet to be established. |
2021-12-12 |
2023-08-13 |
Not clear |
| Sarah Gutkind, David S Fink, Dvora Shmulewitz, Malka Stohl, Deborah Hasi. Psychosocial and health problems associated with alcohol use disorder and cannabis use disorder in U.S. adults. Drug and alcohol dependence. vol 229. issue Pt B. 2021-12-12. PMID:34763137. |
although the problems associated with alcohol use disorder (aud) are well known, little is known about the psychosocial problems associated with cannabis use disorder (cud), and the harmfulness of cud relative to aud. |
2021-12-12 |
2023-08-13 |
Not clear |